Natural Killer-cell Therapy for Acute Myeloid Leukemia

NCT04347616 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Stop funding

Conditions

Acute Myeloid Leukemia Refractory
Acute Myeloid Leukemia, Relapsed, Adult

Interventions

BIOLOGICAL: UCB-NK cells
DRUG: IL-2

Sponsor

Radboud University Medical Center

Collaborators

[object Object]